Following a favorable preliminary investigation of Pacatal' at the Saskatchewan Training School, an extensive evaluation was undertaken to determine the drug's utility and safety in the management of mentally retarded disturbed patients. Thirty-six patients (4 men and 32 women) were chosen at random for treatment; 16 also had epilepsy. Four were classified as morons, 6 as imbeciles, and 26 as idiots. The average I.Q. was 22; average age was 29 years. The term "mentally retarded, disturbed," has wide implications and is generally used without standard definition, we therefore included in this category all extremely hyperactive, restless, violent, destructive, self-abusive mentally retarded individuals.
During the 17-month evaluation period, response to treatment was determined from: 1) daily behavior reports and progress notes of the physicians and nursing staff; 2) numerical averages obtained from Behavior Charts on which the patients were given from 1 to 3 demerits for each misbehavior episode. To assure maximum objectivity, general terms such as "improved", were to be excluded and exact statements concerning changes in behavior patterns were requested, i.e., decrease in misbehavior, increased desire to participate in recreational and occupational therapy, and increased activity in cottage affairs.
The starting dosage of Pacatal ranged from 25 mg per day to 75 mg three times daily, and maintenance dosage ranged from 25 mg every other day to 125 mg three times daily. Medications were routinely administered orally; the intramus-cula~route being employed only in the "l'acatal is the trade-marked name for mepazine supplied by Warner-Chilcott Laboratories, Morris Plains, New Jersey.
oAbbreviation of a paper delivered at The 83rd Annual Meeting of The American Association on Mental Deficiency in Milwaukee, Wisconsin, on May lth, 1959. management of major disturbances. Complete blood studies and urinalaysis were performed monthly.
Results
It is extremely difficult to determine improvement of mentally retarded patients on the metric scales. Horenstein measures improvement by decrease in hyperactivity, destructive behavior, and negativism and by increase in social awareness. This method was followed in the classification of results.
Of the 36 patients, 8 (22%) showed very good improvement; 11 (30%), good improvement; 9 (25%), fair improvement; 1 (2.7%), slight improvement; 7 ( 19%), no improvement. The intensity and number of convulsions occurring in the 16 epileptics were noticeably reduced and some patients could be maintained on greatly decreased amounts of anticonvulsant drugs.
Improvement was neither sudden nor dramatic. Gradually, however, patients became less noisy and hyperkinetic; aggressiveness and destructiveness decreased; and violent incidents were remarkably reduced. Frequency of isolation decreased by 75% and fractures and other accidents requiring surgery were reduced by 80%. Cottage atmosphere became peaceful and happier and striking improvement was noticed in the patients' eating and toilet habits. Facial expressions became more alert; an effect some investigators relate to a decrease in constant strain and tension which occurs after prolonged use of sedatives. Patients began to respond to simple commands and to participate in cottage activities. Eleven patients started to attend shows regularly; and sixteen started recreational and occupational therapy. Many patients began to react favorably to previously rejected kindness. It was also apparent that more insight into the specific character of severely retarded patients was possible and contact with many previously withdrawn patients was established for the first time.
With two exceptions, side effects were mild and transient, the majority being due to the parasympathetic activity which Pacatal possesses. The drug was permanently discontinued in one patient who developed leucopenia. Another patient became jaundiced (this occurred simultaneously with an epidemic of infectious hepatitis at the school) and Pacatal was discontinued. The drug was restarted after liver function tests returned to normal and jaundice did not recur.
Resume
Cette etude avait pour objet de determiner l'utilite et l'innocuite du PA-CAT AL dans Ie maniement des malades troubles, atteints d'arrieration mentale.
Le groupe comptait des debiles simples, des imbeciles et des idiots, soit 36 en tout, avec un quotient intellectuel moyen de 
